Past Annual Fund Acquisions

2O12, 2O11, 2O1O & 2OO9 Technology Acquisition Fund
Proceeds from Celebration for Life support the Technology Acquisition Fund at The Ohio State University Comprehensive Cancer Center— Arthur G. James Cancer Hospital and Richard J. Solove Research Institute. Funds from tonight’s event will purchase new technology in the new James Cancer Hospital and Solove Research Institute opening in 2014 as part of the Medical Center’s expansion. It is Ohio State’s commitment to understanding, preventing and curing cancer.
 
2OO8 Flow Cytometer
This sophisticated instrument enables medical scientists to rapidly measure physical and chemical properties of cells and particles. Flow Cytometers, which consist of electrical, digital and optical components, allow for accurate analysis of DNA, cell cycle, cell function and cell death. This analysis is of paramount importance in helping scientists understand the basic properties of cancer in its many forms-  insight that translates to innovative treatment at the OSUCCC-James Cancer Hospital and Solove Research Institute. In 2008, a new Technology Acquisition Fund was created to support the attainment of equipment for the expansion of OSUCCC- James.
 
2OO7 Digital mobile mammography unit and funds for technology needs of the new survivorship center
The addition of this new, high-tech mobile unit with digital mammogram capabilities to The JamesCare comprehensive breast program will greatly enhance our ability to identify and treat breast cancer in Columbus and will provide the opportunity to reach areas of Ohio that do not have easy access to mammography. This will increase the number of mammogram detected breast cancers and provide patients with the ability to participate in clinical trials. It will also allow us to look at different biomarkers that will increase knowledge and impact treatment options. In addition to the mobile unit, proceeds also are supporting the technology needs of the new Survivorship Center.
 
2OO6 Robotic surgical equipment – the daVinci
OSU has become a leader in robotic surgery, impacting surgeons and patients from around the world. The Medical Center’s first robot has been in high demand, and the 2006 gift allowed The James to add
a second robot to its surgical lineup, giving patients and doctors more access to the latest surgical technology. It not only allows us to provide minimally invasive treatment for prostate cancer, but also  positions The James and the entire OSU Medical Center to expand the use of surgical robots to treat other types of cancer and a variety of non-cancerous conditions at The Ohio State University’s Center for Robotics and Computer-Assisted Surgery.
 
2OO5 Stereotactic radiosurgery and image-guided radiation therapy
This technology provides non-surgical treatment to tumor sites outside the brain with pinpoint accuracy to reduce damage to healthy tissue. The equipment complements the Department of Radiation Medicine’s existing Stereotactic Radiosurgery program which currently treats only brain tumors.
 
2OO4 Robotic surgical equipment and technology
With the acquisition of this technology, the OSU caner program successfully recruited world-class experts to its robotics and minimally invasive urological surgery program. OSUMC surgeons have been able to perform surgeries with greater precision and dexterity, allowing patients to recover more quickly, with minimal pain and with an earlier return to normal activities.
 
2OO3 Intra-operative MRI system
The physicians of the Neurological Surgery Department are able to better diagnose and treat certain types of cancer with this intra-operative technology unlike any other in central Ohio. This system provides a valuable adjunct to standard neurological care which allows the surgeon full access to the patient and provides state-of-the-art imaging during surgery.
 
2OO2 PET/CT scanner
The acquisition of a Siemens PET/CT scanner combined the imaging technologies of position emission tomography (PET) and computer tomography (CT) to offer the ultimate imaging performance for improved diagnosis and treatment in oncology, neurology and cardiology.
 
 

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) 300 W. 10th Ave. Columbus, OH 43210 Phone: 1-800-293-5066 | Email: jamesline@osumc.edu